FDLS Among Factor ETFs
End-of-day Nov 19, 2026 · 46 Factor ETFs by 3Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.4% | −5.9% | −8.2% | −11.4% | +7.8% | +12.9% | +55.8% | — | — | +68.3% |
| Peer average | −1.8% | −5.0% | −6.5% | −6.6% | +7.0% | +11.0% | +55.5% | +47.8% | +212.1% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$19 of every $1,000 in FDLS is Telos
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | TLSTelos | Technology | 1.90% | $189.61 | 623K | $4.6M |
| 2 | FLYWFlywire -vot | Industrials | 1.31% | $131.28 | 147K | $3.2M |
| 3 | GCTGigacloud Tech | Technology | 1.31% | $131.10 | 49K | $3.2M |
| 4 | CONConcentra Group | Healthcare | 1.26% | $126.20 | 73K | $3.1M |
| 5 | TCMDTactile Systems | Healthcare | 1.25% | $125.20 | 115K | $3.0M |
| 6 | BIPBrookfield Infra | Utilities | 1.24% | $124.12 | 72K | $3.0M |
| 7 | BEKEKE | Real Estate | 1.24% | $123.61 | 163K | $3.0M |
| 8 | VCTRVictory Capita | Financial Services | 1.23% | $123.06 | 25K | $3.0M |
| 9 | CTRICenturi | Utilities | 1.22% | $121.80 | 136K | $3.0M |
| 10 | ASNDAscendis Pharma | Healthcare | 1.21% | $121.21 | 11K | $2.9M |
| 11 | TPCTutor Perini COR | Industrials | 1.21% | $120.67 | 31K | $2.9M |
| 12 | KINSKingstone COS IN | — | 1.20% | $119.59 | 130K | $2.9M |
| 13 | JKHYJack Henry | Technology | 1.19% | $119.20 | 17K | $2.9M |
| 14 | PMTSCPI Card Group I | Financial Services | 1.18% | $118.49 | 108K | $2.9M |
| 15 | AIIAmerican Integri | Financial Services | 1.18% | $118.17 | 97K | $2.9M |
of the $162B in 60 Factor ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | TLS | Telos | 1.90% |
| 2 | FLYW | Flywire -vot | 1.31% |
| 3 | GCT | Gigacloud Tech-a | 1.31% |
| 4 | CON | Concentra Group | 1.26% |
| 5 | TCMD | Tactile Systems | 1.25% |
| 6 | BIP | Brookfield Infra | 1.24% |
| 7 | BEKE | KE - | 1.24% |
| 8 | VCTR | Victory Capita-a | 1.23% |
| 9 | CTRI | Centuri | 1.22% |
| 10 | ASND | Ascendis Pharma | 1.21% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 25, 2026 | Oct 1, 2026 | $0.0748 |
| Jun 26, 2026 | Jul 1, 2026 | $0.0899 |
| Mar 27, 2026 | Apr 1, 2026 | $0.0919 |
| Dec 17, 2025 | Dec 24, 2025 | $0.0957 |
| Sep 26, 2025 | Oct 1, 2025 | $0.0621 |
| Jun 26, 2025 | Jul 1, 2025 | $0.10 |
| Mar 27, 2025 | Apr 1, 2025 | $0.0472 |
| Dec 16, 2024 | Dec 23, 2024 | $1.91 |
| Sep 25, 2024 | Oct 2, 2024 | $0.0783 |
| Jun 25, 2024 | Jul 2, 2024 | $0.0823 |
| Mar 27, 2024 | Apr 2, 2024 | $0.0700 |
| Dec 14, 2023 | Dec 20, 2023 | $0.12 |